Cerebrospinal fluid and plasma distribution of myo-inositol and other polyols in Alzheimer disease.
H U Shetty, H W Holloway, M B Schapiro
Index: Clin. Chem. 42(2) , 298-302, (1996)
Full Text: HTML
Abstract
Previous studies suggest the presence of increased concentrations of cerebral myo-inositol in Alzheimer disease (AD). To characterize this abnormality further, we quantified myo-inositol and several other polyols in cerebrospinal fluid (CSF) and plasma from 10 AD subjects and 10 healthy age-matched controls by using a gas chromatographic-mass spectrometric technique. The mean CSF concentration and CSF/plasma concentration ratio of myo-inositol in AD were not significantly different from those determined in control subjects. Also, concentration profiles of other polyols were not significantly altered in AD. CSF and plasma myo-inositol concentrations were correlated in control subjects but not in AD subjects. However, a significant correlation between CSF and plasma 1,5-anhydrosorbitol (a polyol internal control) concentrations observed in control subjects was retained in AD subjects.
Related Compounds
Related Articles:
2015-05-01
[Bioprocess Biosyst. Eng. 38(5) , 889-903, (2015)]
2015-04-21
[Analyst 140(8) , 2785-96, (2015)]
2014-04-01
[Pharmacogn. Mag. 10(Suppl 2) , S383-91, (2014)]
The fused anthranilate synthase from Streptomyces venezuelae functions as a monomer.
2015-02-01
[Mol. Cell Biochem. 400(1-2) , 9-15, (2015)]
2014-12-01
[Oncol. Rep. 32(6) , 2380-6, (2014)]